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Cardiovascular autonomic dysfunction in uremia. Cardiovascu- to dialysis complications, including intra-dialytic hypo-
lar morbidity and mortality is common in chronic renal failure tension, and cardiovascular mortality.
patients, and may be explained in part by abnormalities in car-
diovascular autonomic regulation. This review discusses the
results of cardiovascular autonomic function studies in chronic CARDIAC BARORECEPTOR SENSITIVITY
renal failure patients. While covering most methods of assess-
The baroreceptor reflex arc is the principal mechanisming autonomic function, we focus particularly on power spectral
analysis methods. These newer techniques are non-invasive, re- in the short-term regulation of the cardiovascular system,
producible, and allow the rapid assessment of the integrity of including blood pressure changes. The main barorecep-
cardiovascular autonomic reflexes at the bedside. The abnor-
tor sites are in the carotid sinuses, the enlarged parts ofmalities of parasympathetic, sympathetic and cardiac baro-
the internal carotid arteries just above the bifurcationreceptor function seen in dialysis-dependent patients are high-
lighted, and their significance in intra-dialytic hypotension and of the common carotid arteries, as well as the aortic arch
cardiovascular mortality as well as the effects of dialysis and and its proximal branches. Free and encapsulated baro-
transplantation on these parameters examined. Importantly, receptor nerve endings are embedded in the adventitialstudies of cardiovascular autonomic dysfunction in pre-dialysis
layer of the arterial wall. These tonically discharge viachronic renal failure patients, when abnormalities may be ame-
afferent fibers in the glossopharyngeal (carotid) and va-nable to intervention to prevent progression and premature
cardiovascular morbidity and mortality, are reviewed. gus (aortic) nerves to specialized nuclei within the brain-
stem, including the nucleus tractus solitarius, nucleus
ambiguous, and the ventrolateral nuclei of the medulla
Cardiovascular disease is the leading cause of mortal- oblongata. Afferent discharge is increased by stimulation
ity in hemodialysis patients, accounting for 44% of the of the baroreceptor nerve endings secondary to stretch-
overall mortality [1]. Indeed, for hemodialysis patients ing of the arterial wall brought about by increased trans-
15 to 30 years old, the incidence of cardiovascular death mural pressure related to increased blood pressure. Equally
is 150 times greater than the general population [2]. A afferent discharge is decreased by reduced blood pres-
number of mechanisms have been proposed to explain sure, reduced transmural pressure, and reduced stretch.
this excess cardiovascular mortality, including hyperten- Central fibers in the brainstem nuclei may be influenced
sion, arterial stiffness and cardiovascular autonomic dys- by the hypothalamus, cerebral cortex, and other higher
function. This review focuses on the reported abnormali- brain centers. Efferent discharge via the parasympathetic
ties in cardiovascular autonomic function with studies and sympathetic outflow tracts influences sinoatrial node,
utilizing both traditional invasive and recent non-inva- ventricular wall, arteriolar and capacitance vessel func-
sive techniques, in particular discussing the possible dif- tion in responses to the precipitating blood pressure
ferential effects on parasympathetic and sympathetic change. Therefore, assessments of baroreceptor sensitivity
nervous system dysfunction. The effects of dialysis and can provide a measure of the overall integrity of auto-
renal transplantation on cardiovascular autonomic dys- nomic nervous system function.
function are covered as well as its significance with regard
Intra-arterial techniques
Key words: baroreceptor reflex arc, blood pressure, heart, parasympa- Classically, invasive intra-arterial techniques are used
thetic nervous system, power spectral analysis techniques, sympathetic
to assess heart rate responses to either pressor (phenyl-nervous system, dialysis, hemodialysis, intradialytic hypotension, peri-
toneal dialysis, renal transplantation, chronic renal failure. ephrine, angiotensin) or depressor stimuli (amyl nitrite,
sodium nitroprusside). The regression of pulse interval
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Table 1. Results of studies assessing baroreceptor sensitivity in chronic renal failure patients
Study Population Test Findings
Pickering et al, 32 HD IV bolus phenylephrine – Reduced BRS in HD compared to controls (historical)
1972 [4] – BRS inversely correlated with age and hypertension, though
correlation weaker in HD patients
Lazarus et al, 13 CRF IV bolus angiotensin – Reduced BRS in normotensive (2.1 msec/mm Hg) and hypertensive
1973 [5] (9 hypertensive) Inhaled amyl nitrite CRF (1.3) compared to controls (9.1) for pressor stimulus
5 Controls (angiotensin)
– Reduced BRS in normotensive (2.5 msec/mm Hg) and hypertensive
CRF (2.3) compared to controls (9.1) for depressor stimulus (amyl
nitrite)
Bondia et al, 1988 10 HD IV bolus phenylephrine – Reduced BRS in HD (3.08 vs. 11.35 msec/mm Hg)
[6] 8 Controls
Heber et al, 1989 10 HD VS – All but 1 patient had square wave (abnormal) response (initial BP
[7] 5 Controls increase, plateau with no fall, post-release gradual BP reduction
with no overshoot)
Agarwal et al, 25 CRF IV bolus phenylephrine – Reduced BRS in CRF (3.88 vs. 11.2 msec/mm Hg)
1991 [8] 8 Controls – 8 patients restudied on HD, BRS lower in hypotension-prone vs.
normotensive group (3.10 vs. 5.32 msec/mm Hg)
– 12 patients restudied after RT, BRS improved (7.46 vs. 3.95 msec/
mm Hg)
Gerhardt et al, 20 HD 2- to 4-beat sequences of – Reduced BRS in CRF vs. Controls (5.2 vs. 13.4 msec/mm Hg)
1999 [17] 20 RT concordant increases or – Similar BRS in RT and Controls (11.2 vs. 13.4 msec/mm Hg)
20 Controls decreases in BP and PI
Bald et al, 2001 27 CRF Sequence analysis – Reduced BRS in HD, not CRF, vs. Controls
(abstract) 20 HD
27 Controls
Carr et al, 2001 83 CRF Combined -index (FFT) – Reduced BRS in 54 severe CRF (7.3 msec/mm Hg) compared
(abstract) 24 Controls to 29 mild-to-moderate CRF patients (12.0) and Controls (10.5)
Abbreviations are: CRF, chronic renal failure; HD, hemodialysis; BRS, baroreceptor sensitivity; VS, Valsalva maneuver; RT, renal transplant; BP, blood pressure;
PI, pulse interval; FFT, fast Fourier Transform.
impaired baroreceptor sensitivity in chronic renal failure. Non-invasive techniques
Furthermore, there was an inverse relationship between The advent of newer, reliable, non-invasive techniques
baroreceptor sensitivity and age and blood pressure, but of beat-to-beat blood pressure measurement [9, 10], to-
this was less marked than in control subjects. Finally, baro- gether with the increased availability of powerful micro-
receptor sensitivity appeared to improve with long-term computers and appropriate analysis techniques has made
hemodialysis in the six patients re-studied (Table 1) [4]. possible the calculation of cardiac baroreceptor sensitiv-
This observation of impaired baroreceptor sensitivity ity from the assessment of continuous blood pressure
in chronic renal failure has been confirmed by a number and pulse interval recordings taken at rest. Blood pres-
of other studies, utilizing different techniques [5–8] (Ta- sure and pulse interval variability can be described in
ble 1). Lazarus and colleagues reported impaired baro- terms of the underlying rhythmic factors affecting the
receptor sensitivity in both four normotensive and nine cardiovascular system, including the cardiac cycle, the
hypertensive dialysis-independent chronic renal failure respiratory cycle, and vasomotor activity [11]. The tech-
patients using pressor (angiotensin) and depressor (amyl nique of power spectral analysis with the use of fast
nitrite) techniques [5]. Bondia and colleagues initially Fourier Transform can be used to detect such underlying
studied 52 hemodialysis patients, and identified ten with rhythmicity by assessing the number, frequency, and am-
an abnormal Valsalva ratio. This group was then studied plitude of the oscillatory components (frequency domain
in more detail to identify the segments of the autonomic analysis) [12]. Cardiac baroreceptor sensitivity can be
reflex arc affected. Abnormalities were identified in re- estimated by calculation of the square root of the ratio
sponse to bolus phenylephrine (afferent common) and of powers of pulse interval to systolic blood pressure,
atropine (efferent vagal) [6]. Heber and colleagues as- the -index, which has been shown to correlate well with
sessed intra-arterial blood pressure responses to the Val- cardiac baroreceptor sensitivity calculated by means of
salva maneuver, and reported a square wave response, the ‘gold standard’ pharmacological techniques [13, 14].
that is, an initial blood pressure increase with a plateau Utilizing these techniques, we have recently reported re-
thereafter and a gradual reduction with no overshoot fol- duced cardiac baroreceptor sensitivity in dialysis-inde-
lowing release. This is consistent with an impaired baro- pendent chronic renal failure patients with severely im-
receptor reflex arc, and was hypothesized to be second- paired function [glomerular filtration rate (GFR)30 mL/
min] compared to those patients with mildly impairedary to chronic fluid overload and arterial stretching [7].
Robinson and Carr: Uremia and CVD 1923
function (GFR 30 to 80 mL/min) and control subjects pared to 60 control subjects, though there were no differ-
ences between the two chronic renal failure groups [20].(Table 1) (abstract; Carr et al, J Am Soc Nephrol 12:
A0352, 2001). Rockel and colleagues compared heart rate and blood
pressure responses to the Valsalva maneuver and ortho-Blood pressure and pulse interval also can vary as a
function of time. Therefore, analysis of beat-to-beat blood stasis in chronic renal failure with moderately (GFR 10
to 30 mL/min) and severely impaired (GFR 4 to 10 mL/pressure and pulse interval recordings of at least 10 min-
utes taken at rest can be used to assess cardiac barorecep- min) renal function as well as in hemodialysis patients.
In moderately impaired renal failure patients, 50% dem-tor sensitivity (time domain analysis). Recordings are
analyzed to document sequences of typically at least onstrated abnormal heart rate responses to the Valsalva
maneuver and 18% to orthostasis. This worsened in se-three beats associated with increasing blood pressure and
pulse interval (pressor sequences) or decreasing blood vere renal failure patients to 58% and 31%, respectively,
and to 60% and 40% in hemodialysis patients [19].pressure and pulse interval (depressor sequences). These
are associated with the baroreceptor reflex, and account Few studies have longitudinally assessed the parasym-
pathetic nervous system function in chronic renal failurefor at least 20% of beats in typical recordings [15, 16].
Utilizing this technique, Gerhardt and colleagues have patients [26, 36, 37]. Solders, Persson and Gutierrez have
reported worsening heart rate variability with increasingreported impaired baroreceptor sensitivity for both pres-
sor and depressor sequences in 20 hemodialysis chronic time on hemodialysis [26]. Vita and colleagues, who re-
ported deterioration in heart rate responses to respira-renal failure patients compared to control subjects (Ta-
ble 1) [17]. In a study of 27 dialysis-independent children tion 18 months after commencing hemodialysis in a se-
ries of 19 patients, confirmed this finding. Indeed, 33%with impaired renal function, Bald and colleagues have
provisionally reported no significant difference in baro- of patients with normal tests of autonomic function at
baseline had deteriorated by 18 months, and 62.5% byreceptor sensitivity to an age-matched control popula-
tion, though the control group had lower systolic blood 56 months [36]. However, there were mixed messages
from this study, as 43% of patients had an improvementpressure values (Table 1) [abstract; Bald et al, J Hyper-
tens 19(Suppl 2):S212, 2001]. in their autonomic score by 18 months, and 50% by 56
months [36]. Furthermore, 8 patients re-studied at 92
months after commencing hemodialysis demonstrated
PARASYMPATHETIC NERVOUS SYSTEM an improvement in heart rate responses to respiration
Classical techniques when compared to 56 months. This improvement was
attributed to a change to bicarbonate dialysis [37].Standard assessments of the integrity of the parasym-
Age also may be an important factor in parasympa-pathetic nervous system include the measurement of heart
thetic dysfunction. Jassal, Douglas and Stout found thatrate responses to respiration, orthostatic change and the
65.9% of their dialysis group over the age of 65 yearsValsalva maneuver [18]. A number of studies have con-
had abnormal parasympathetic function tests, but onlysistently reported impairment of parasympathetic ner-
33.3% of patients under the age of 65 years were affected.vous system function in both pre-dialysis [8, 19–22] and
Nonetheless, chronic renal failure remained importanthemodialysis-dependent chronic renal failure patients
in the cause of parasympathetic dysfunction, as onlyusing these techniques (Table 2) [6, 19–21, 23–35]. Only
11.8% and 0% of the comparator control groups wereone study has reported intact parasympathetic nervous
affected, respectively [34]. However, Agarwal and col-system function, though this was a small study of 10
leagues found evidence of parasympathetic dysfunctionhemodialysis patients utilizing heart rate responses to
in their study population of mean age 28.5 years old [8].orthostatic change as the only assessment of parasympa-
Vita and colleagues also found evidence of parasympa-thetic function (Table 2) [7]. Few studies have directly
thetic dysfunction in young (35 to 53 years) hemodialysiscompared parasympathetic nervous system function in
patients (9%), but significantly higher levels in thosea pre-dialysis and hemodialysis-dependent chronic renal
aged 66 to 76 years (66%) [29]. Interestingly, in a laterfailure population. Heidbreder and colleagues assessed
study, they reported no relationship between autonomicheart rate responses to respiration, orthostatic change
dysfunction and either age or dialysis duration [35].and the Valsalva maneuver in 31 chronic renal failure
and 35 hemodialysis patients. They demonstrated that
Power spectral analysis techniquesboth groups had abnormal heart rate responses when
compared to a control population, though there were In addition to the assessment of cardiac baroreceptor
sensitivity, the technique of power spectral analysis withno significant differences between the two chronic renal
failure groups [21]. Similarly, Campese and colleagues the use of fast Fourier Transform can be used to assess
the integrity of the underlying sympathovagal balancereported a significantly reduced Valsalva ratio in 21
chronic renal failure and 16 hemodialysis patients com- of autonomic cardiovascular system control [11, 38, 39].
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Table 2. Results of studies assessing parasympathetic nervous system function in chronic renal failure patients
Study Population Test Findings
Ewing et al, 1975 26 HD HR responses to – 50% had abnormal/borderline HR response to VS
[23] respiration, VS – Abnormal VS ratio correlated with reduced respiratory HR
variability
Campese et al, 21 CRF HR responses to VS – Impaired VS ratio in CRF (1.51) and HD patients (1.62) compared to
1981 [20] 16 HD Controls (2.10)
60 Controls
Naik et al, 1981 27 HD HR responses to tilt, VS – Reduced 30:15 HR ratio on standing in HD group
[24] 15 Controls
Zoccali et al, 1982 18 HD HR responses to respiration, – Impaired HR responses in HD vs. Controls (respiration, 12 vs.
[25] 12 Controls tilt, VS, atropine 23 bpm; tilt, 1.06 vs. 1.26; VS, 1.53 vs. 1.83)
– Reduced tachycardia response to atropine in HD vs. Controls
(34 vs. 41 bpm)
Heidbreder et al, 31 CRF HR responses to respiration, – Impaired HR responses in CRF vs. Controls (respiration, 21 vs.
1985 [21] 35 HD tilt, VS 54 bpm; Tilt, 1.03 vs. 1.16; VS, 1.18 vs. 1.46)
18 RT – Impaired HR responses in HD vs. Controls (respiration, 35 vs.
37 Controls 54 bpm; tilt, 1.06 vs. 1.16; VS, 1.27 vs. 1.46)
– No significant differences between HR responses between
RT vs. Controls (respiration, 57 vs. 54 bpm; tilt, 1.23 vs. 1.16;
VS, 1.38 vs. 1.46)
Solders et al, 1985 44 HD HR responses to respiration – HR variability reduced in HD patients with (14) and without (30) hyper-
[26] 45 Controls parathyroidism, i.e. unrelated to duration of uremia
Malik et al, 1986 19 CRF HR responses to respiration, – 32% of all patients had early PNS dysfunction
[27] 40 HD tilt, VS – 39% of all patients had definite PNS dysfunction
8 PD – No significant differences between groups in degree of PNS
dysfunction
Mallamaci et al, 12 HD HR responses to respiration, – Reduced HR responses in both HD and PD groups compared
1986 [28] 10 PD tilt, VS to Controls
11 RT – No significant difference in HR responses between HD and
12 Controls PD groups
– No significant differences between HR responses in RT and
Control groups
Vita et al, 1987 20 HD HR responses to respiration, – PNS dysfunction (2 abnormal tests) more common in elderly (66–76
[29] tilt, VS years) than young (35–53) group (66 vs. 9%)
Bondia et al, 1988 10 HD HR responses to atropine – Reduced tachycardic response to 0.015mg/kg atropine bolus in HD vs.
[6] 8 Controls Controls (29 vs. 59 bpm)
Heber et al, 1989 10 HD HR responses to tilt – No significant difference HD vs. Controls (1.13 vs. 1.26)
[7] 5 Controls
Heidebreder et al, 27 HD HR responses to respiration, – Impaired responses in HD vs. Controls (respiration, 35 vs. 54 bpm; tilt,
1989 [31] 37 Controls tilt, VS 1.04 vs. 1.16; VS, 1.24 vs. 1.46)
Vita et al, 1989 35 HD HR responses to respiration, – 14% of patients had 2 abnormal tests
[32] tilt, VS
Agarwal et al, 25 CRF HR responses to respiration, – Impaired HR responses in CRF vs. Controls (respiration, 1.14 vs. 1.62;
1991 [8] 8 Controls tilt, VS Tilt, 1.03 vs. 1.12; VS, 1.34 vs. 1.79)
– Improvement in HR responses to respiration in 8 HD patients (1.14 vs.
1.19), though other parameters unchanged (tilt, 1.06 vs. 1.03; VS, 1.33
vs. 1.46)
– Improvement in HR responses in 12 RT patients (respiration, 1.13 vs.
1.34; tilt, 1.05 vs. 1.08; VS, 1.37 vs. 1.65)
De Vecchis et al, 7 CRF HR responses to respiration, – PNS damage in 100% CRF, 62.5% LV dysfunction and 87.5% both
1994 [22] 8 LV dysfunction tilt, VS patients
8 Both atropine test
Jassal et al, 1997 71 HD HR responses to respiration, – 61% of patients had abnormal tests
[33] tilt, VS
Hathaway et al, 43 CRF HR responses to – Reduced respiratory HR variability in CRF (14 bpm), HD (15) and PD
1998 [44] 168 HD respiration, VS (13) groups compared to Controls (25)
61 PD – Reduced VS ratio in CRF (1.4), HD (1.3) and PD (1.3) groups compared
67 Controls to Controls (1.7)
Jassal et al, 1998 41 HD/PD HR responses to respiration, – Higher percentage of patients compared to Controls with impaired HR
[34] (65 yrs) tilt, VS responses in both older (respiration, 73.2 vs. 35.3%; tilt, 58.5 vs. 17.6%;
42 HD/PD VS, 58.5 vs. 5.9%) and younger groups (respiration, 17.6 vs. 4.3%; tilt,





Vita et al, 1999 30 HD HR responses to respiration, – 37% of patients had at least 1 abnormal test
[35] tilt, VS – 40% of patients had 1 abnormal test
Abbreviations are: CRF, chronic renal failure; HD, hemodialysis; PD, peritoneal dialysis; RT, renal transplant; BP, blood pressure; HR, heart rate; VS, Valsalva
maneuver; bpm, beats per minute.
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Table 3. Results of studies assessing autonomic nervous system function in chronic renal failure patients by spectral analysis techniques
Study Population Test Findings
Axelrod et al, 10 CRF PI spectra (FFT) – Reduced LF (0.1–0.2 Hz) power in all patients vs. Controls (0.27  104 vs.
1987 [45] 8 HD 0.95  104 msec2), with non-significantly greater reductions in HD and PD
7 PD vs. CRF
30 Controls – Reduced HF (0.2–0.3 Hz) power in all patients vs. controls (0.49  104 vs.
0.17  103)
Cloarec-Blanchard 6 HD SBP spectra (FFT) – Reduced LF (0.06–0.13 Hz) power on standing in HD vs. Controls (340 vs.
et al, 1992 [46] 6 Controls 740 mm Hg2)
– No differences when supine (327 vs. 523 mm Hg2)
Takahashi et al, 11 HD PI spectra (AR) – Reduced LF (0.04–0.14 Hz) power HD vs. Controls supine (11 vs. 21 msec2)
1996 [47] 10 Controls and standing (12 vs. 26 msec2)
– Reduced HF (0.25 Hz) power HD vs. Controls supine (15 vs. 25 msec2) and
standing (11 vs. 15 msec2)
– Reduced LF/HF ratio HD vs. Controls supine (0.7 vs. 1.1) and standing
(1.1 vs. 2.1)
Hathaway et al, 43 CRF PI spectra (FFT) – Reduced LF (0.04–0.15 Hz) power in CRF (4.3 msec2), HD (4.4) and PD
1998 [44] 168 HD patients (4.0) vs. Controls (6.4)
61 PD – Reduced HF (0.15–0.4 Hz) power in CRF (3.6 msec2), HD (3.6) and PD
48 Controls patients (3.2) vs. Controls (5.1)
Rubinger et al, 14 HD PI spectra (AR) – Reduced LF (0.05–0.15 Hz) and HF (0.15–0.4 Hz) powers in HD vs. Controls
1999 [48] 8 RT (LF, 1047 vs. 3515 msec2; HF, 267 vs. 991)
14 Controls – No significant differences in LF and HF powers in RT vs. Controls (LF, 2832
vs. 3933 msec2; HF, 810 vs. 1571)
Vita et al, 1999 30 HD PI spectra (AR) – No significant differences in LF (0.03–0.15 Hz) and HF (0.15–0.33 Hz) powers
[35] (19 with AN) HD vs. Controls supine (LF, 44 vs. 54 nu; HF, 26 vs. 23)
20 Controls – No significant differences in LF and HF powers HD patients with vs. without
AN supine (LF, 39 vs. 53 nu; HF, 25 vs. 28)
– Reduced LF but not HF power HD vs. Controls standing (LF, 52 vs. 72 nu;
HF, 16 vs. 15)
– Reduced LF but not HF power HD patients with vs. without AN standing
(LF, 50 vs. 56 nu; HF, 16 vs.17)
Bald et al, 2001 20 HD SBP spectra (AR) – Reduced LF (0.04–0.15 Hz)/HF (0.15–0.4 Hz) ratio for SBP spectra between
(abstract) 27 CRF PI spectra (AR) HD but not CRF patients and Controls
27 Controls – No significant differences in LF/HF ratio for PI spectra between HD, CRF
and Control groups
Carr et al, 2001 83 CRF PI spectra (FFT) – PI: Reduced LF (0.05–0.15 Hz) power severe CRF (23 nu) compared to mild-
(abstract) (54 severe) SBP spectra (FFT) to-moderate CRF (29) and Controls (29), but no differences in HF (0.2–0.35
24 Controls Hz) power (19 vs. 16 vs. 19)
– SBP: Reduced LF power severe CRF (15 nu) compared to mild-to-moderate
CRF (24) and controls (31), but no differences in HF power (8 vs. 7 vs. 6)
Giordano et al, 11 HD PI spectra (AR) – Increased LF (0.04–0.15 Hz) power HD vs. Controls (72.4 vs. 47.2 nu)
2001a [49] 10 Controls – Reduced HF (0.16–0.45 Hz) power HD vs. Controls (18.7 vs. 54.5 nu)
– Increased LF/HF ratio HD vs. Controls (5.6 vs. 0.8)
Abbreviations are: HD, hemodialysis; SBP, systolic blood pressure; FFT, fast Fourier Transform; LF, low frequency; PI, pulse interval; AR, autoregressive; HF,
high frequency; AN, autonomic neuropathy; nu, normalized units; CRF, chronic renal failure. Only normotensive hemodialysis patients from these studies have been
included in Table 3; see Table 5 for comparison of hypotension-prone and normotensive hemodialysis patients.
a Only non-diabetic hemodialysis-dependent chronic renal failure subjects were included
interval spectra between 30 hemodialysis patients andThe high frequency power (0.20 to 0.35 Hz) of the de-
20 control subjects (Table 3) [35]. Again, there have beencomposed spectrum of pulse interval variability is a reli-
few studies of pre-dialysis chronic renal failure patients,able marker of vagal activity [11, 38, 40]. In particular,
though Axelrod and colleagues have compared the midthe use of physiological measures recognized to increase
(vagal) and high (respiratory and vagal) frequency pulsevagal drive, such as controlled respiration, cold facial
interval powers in dialysis-dependent and dialysis-inde-stimulation and rotational stimuli, result in an increase
pendent chronic renal failure. Greater reductions werein the high frequency peak [41, 42]. Conversely, the use
seen in peritoneal and hemodialysis compared to dial-of pharmacological vagal blockade with atropine practi- ysis-independent patients, all chronic renal failure pa-
cally abolishes pulse interval variability in the high fre- tients have lower vagal powers than control subjects
quency band [41, 43]. (Table 3) [45]. We further studied dialysis-independent
Using these techniques, there is a consistent reduction patients with increasing degrees of chronic renal failure,
in high frequency power compatible with parasympa- and the data show no differences in high frequency
thetic dysfunction in hemodialysis patients (Table 3) [44, power between patients with mild-to-moderate and se-
45, 47–49]. However, Vita and colleagues found no sig- vere chronic renal failure, and control subjects (unpub-
lished data and Table 3).nificant differences in high frequency power of the pulse
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SYMPATHETIC NERVOUS SYSTEM clusions with only some research groups demonstrating
reduced low frequency power of pulse interval [35, 48]Classical techniques
and systolic blood pressure variability (Table 3) [46]. Inter-
Standard assessments of the integrity of the sympa- estingly, Cloarec-Blanchard and colleagues reported a sig-
thetic nervous system include the measurement of blood nificant difference in systolic blood pressure powers be-
pressure responses to orthostatic change and pressor tween hemodialysis patients and control subjects on
stimuli, including handgrip, mental arithmetic and cuta- standing, that is, when there should be sympathetic hy-
neous cold [18]. Unlike the results of studies assessing the peractivity, and consistent with uremia-related sympa-
parasympathetic nervous system, the conclusions vary. thetic neuropathy [46]. However, other groups have re-
Some studies report abnormal sympathetic nervous sys- ported increased low frequency powers (Table 3) [49].
tem function in chronic renal failure patients [5, 19–21, Indeed, Giordano and colleagues have suggested that
23, 27, 29, 30, 32–35], though others report normal func- this increased sympathetic activity may predispose to
tion (Table 4) [6–8, 22, 24, 25, 28, 31]. Indeed, exagger- sudden cardiac death in waiting list renal transplant pa-
ated hypertensive responses to mental arithmetic in pre- tients [49].
dialysis [8] and to cold pressor in hemodialysis chronic However, the low-to-high frequency ratio is probably
renal failure patients [6] have been reported. a more informative assessment of overall cardiovascular
Interestingly, in those chronic renal failure patients with autonomic integrity. Concerning systolic blood pressure
sympathetic dysfunction, there may be an improvement variability, Bald and colleagues reported a reduced low-
following hemodialysis [21]. However, continuing deteri- to-high frequency ratio in 20 hemodialysis-dependent
orating blood pressure responses to orthostatic change chronic renal failure children and adolescents compared
and isometric handgrip have been found after 18 and 56 to controls, indicating autonomic dysfunction. However,
months, respectively, of hemodialysis [36]. As well as as- they did not find any differences compared to controls in
sessing the pressor response to isometric handgrip, Cam- the twenty-seven pre-dialysis patients studied (abstract;
pese and colleagues also assessed the pressor responses Bald at al, ibid). Concerning pulse interval variability,
to a norepinephrine infusion. They reported lower rises Giordano and colleagues reported an increased low-to-
in dialysis-dependent and dialysis-independent chronic high frequency ratio reflecting increased sympathetic ac-
renal failure patients at all three-dose levels of norepi- tivity [49], in keeping with the findings of others [57].
nephrine. They concluded that there was evidence of Changes in the low-to-high frequency ratio have been
end-organ responsiveness to catecholamine in addition specifically demonstrated in hemodialysis patients at risk
to other sympathetic dysfunction [20]. of intra-dialytic hypotension [47, 58–60], which is dis-
cussed in a later section.
Power spectral analysis techniques
Alternative techniques of sympathetic nervousIn addition to the assessment of cardiac baroreceptor
system assessmentsensitivity, the technique of power spectral analysis with
the use of fast Fourier Transform can be used to assess Plasma norepinephrine levels reflect the rate of nor-
the integrity of the underlying sympathovagal balance epinephrine spillover from the synaptic cleft and its rate
of autonomic cardiovascular system control [11, 38, 39]. of removal from plasma, and have been measured also
The low frequency power (0.05 to 0.15 Hz) of the decom- as an assessment of sympathetic nervous system function.
posed spectrum of pulse interval variability may be signifi- Studies have generally reported increased levels of plasma
cantly increased by measures that enhance sympathetic norepinephrine in hemodialysis-dependent chronic renal
drive, including passive tilt or active standing [41, 42, 50, failure patients compared to controls, suggesting either
51] and mental stress induced by arithmetic calculation normal or increased sympathetic nervous system activity
[52, 53]. Pharmacological blockade with propranolol re- [24, 61–66], though others have found no significant differ-
duces low frequency power [54, 55]. However, low fre- ences compared to controls [20, 67]. However, Campese
quency power is not entirely abolished by beta-blockade, and colleagues investigated 16 hemodialysis-dependent
and atropine also may reduce low frequency power albeit and 21 pre-dialysis chronic renal failure patients compared
under conditions of controlled respiration [41]. Further- to 60 control subjects, and identified increased plasma
more, there are a number of other requirements in addi- norepinephrine levels in the pre-dialysis patients only
tion to intact sympathetic nervous system efferents for [20], confirming the findings of Atuk and colleagues [68].
the generation of a low frequency peak, including a reac- The differences in these findings may relate to method-
tive vascular system and an intact baroreflex [56]. There- ology, as well as the reproducibility of laboratory plasma
fore, low frequency power is not entirely a marker of the norepinephrine estimations. However, the reduction to-
sympathetic nervous system, and results should be inter- ward control subject levels in hemodialysis-dependent
preted with caution. patients may reflect the duration, type and efficiency of
dialysis, and these factors may be important in explainingUsing these techniques, there are again different con-
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Table 4. Results of studies assessing sympathetic nervous system function in chronic renal failure patients
Study Population Test Findings
Ewing et al, 1975 26 HD BP responses to handgrip – Abnormal/borderline responses in 45% of patients
[23]
Campese et al, 21 CRF BP responses to handgrip, tilt – Reduced BP rise during handgrip in CRF (15 mm Hg) and HD (21)
1981 [20] 16 HD vs. Controls (28)
60 Controls – Significant orthostatic BP fall in Controls and CRF, but not HD
patients
Naik et al, 1981 27 HD BP responses to handgrip, tilt, – No significant differences in SBP increases HD vs. Controls (hand-
[24] 15 Controls cutaneous cold grip, 25 vs. 29 mm Hg; tilt, 4 vs. 0; cold, 17 vs. 21)
– Significantly lower DBP increase HD vs. Controls for handgrip (18
vs. 30 mm Hg), though other responses not significantly different
(tilt, 5 vs. 10; cold, 15 vs. 17)
Zoccali et al, 1982 18 HD BP responses to tilt, handgrip, – No significant differences in BP increases HD vs. Controls (tilt, 13/10
[25] 12 Controls cutaneous cold vs. 4/8 mm Hg; handgrip, 30/24 vs. 29/27; cold, 23/16 vs. 21/17)
Heidbreder et al, 31 CRF BP responses to tilt, handgrip, – Significant orthostatic SBP and DBP changes in CRF vs. Controls
1985 [21] 35 HD cutaneous cold, mental (20/2 vs. 3/4 mm Hg), though no significant differences in other
18 RT stress tests (grip, 14 vs. 16; cold, 12/9 vs. 17/13; mental, 26/18 vs. 33/23)
37 Controls – No significant differences HD vs. Controls (tilt,6/8 vs. 3/4 mm Hg;
grip, 15 vs. 16; cold, 13/11 vs. 17/13; mental: 29/19 vs. 33/23).
Orthostatic change significantly improves with HD vs. CRF groups
(6/8 vs. 20/2)
– No significant differences RT vs. Controls (tilt: 4/3 vs. 3/4 mm Hg;
grip, 13 vs. 16; cold, 16/11 vs. 17/13; mental, 25/16 vs. 33/23).
Orthostatic SBP change significantly improves with RT vs. CRF
groups (4 vs. 20)
Malik et al, 1986 19 CRF BP responses to handgrip, tilt – 21% had abnormal SNS tests (in addition to definite PNS dysfunc-
[27] 40 HD tion), with no difference between groups
8 PD
Mallamaci et al, 12 HD BP responses to tilt – No significant differences in MAP responses to tilt (HD, 9 mm Hg;
1986 [28] 10 PD PD, 11; RT, 9; Controls, 13)
11 RT
12 Controls
Vita et al, 1987 20 HD BP responses to tilt, handgrip – Autonomic dysfunction (1 abnormal SNS test in association with
[29] 2 abnormal PNS tests) more common in elderly (66–76 years) than
young (35–53) patients (55 vs. 9%)
Bondia et al, 1988 10 HD BP responses to cutaneous – Increased SBP rise in HD vs. Controls (42 vs. 24 mm Hg)
[6] 8 Controls cold
Heber et al, 1989 10 HD BP responses to handgrip – No significant differences HD vs. Controls
[7] 5 Controls
Heidbreder et al, 27 HD BP responses to handgrip, – No significant differences HD vs. Controls (handgrip, 16 vs. 16
1989 [31] 37 Controls tilt, cutaneous cold, mm Hg; tilt, 5/8 vs. 3/4; cold, 14/12 vs. 17/13; mental, 28/19 vs.
mental stress 33/23)
Vita et al, 1989 35 HD BP responses to tilt, handgrip – 26% 1 abnormal SNS test (in association with 2 abnormal PNS
[32] tests)
Agarwal et al, 25 CRF BP responses to tilt, noise, – Increased BP responses to mental stress CRF vs. Controls (16/11
1991 [8] 8 Controls cutaneous cold, mental vs. 10/6 mm Hg), otherwise no significant differences (tilt, 6 vs.
stress 5; noise, 12/7 vs. 18/4; cold, 19/10 vs. 18/10)
– No significant changes in 8 HD patients: (tilt, 7 vs. 9 mm Hg; noise,
14/10 vs. 6/7; cold, 15/7 vs. 15/10; mental, 14/13 vs. 10/10)
– No significant changes in 12 RT patients (noise, 12/6 vs. 10/8 mm Hg;
cold, 19/10 vs. 13/9; mental, 12/10 vs. 10/9)
De Vecchis et al, 7 CRF BP responses to tilt, handgrip, – No evidence of SNS damage
1994 [22] 8 LV dysfunction cutaneous cold
8 Both
Jassal et al, 1997 71 HD BP responses to handgrip, tilt – 63% had abnormal tests
[33]
Jassal et al, 1998 41 HD/PD (65 yrs) BP responses to handgrip, tilt – Higher percentage of patients compared to controls with impaired
[34] 42 HD/PD (65 yrs) BP responses in both older (tilt, 31.7 vs. 0%; grip, 53.7 vs. 29.4%)
17 Controls (65 yrs) and younger groups (tilt, 11.9 vs. 0%; grip, 14 vs. 0%)
23 Controls (65 yrs)
Vita et al, 1999 30 HD BP responses to tilt, handgrip – 13% of patients had evidence of combined SNS and PNS dysfunction
[35]
Abbreviations are: CRF, chronic renal failure; HD, hemodialysis; PD, peritoneal dialysis; RT, renal transplant; BP, blood pressure; SBP, systolic blood pressure;
DBP, diastolic blood pressure; MAP, mean arterial pressure; SNS, sympathetic nervous system; PNS, parasympathetic nervous system.
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differences in dialysis studies. Furthermore, increased to a cold pressor stimulus, suggesting that the defect was
in the afferent limb of the baroreceptor reflex arc [80].catecholamine levels may be related to co-morbid condi-
tions, including congestive cardiac failure, and be associ- This hypothesis is further supported by the normal blood
pressure responses to cold and mental arithmetic re-ated with poorer prognosis [69, 70].
Sympathetic activity also can be directly and accu- ported by Nies and colleagues in a group of five patients
with intradialytic hypotension, who had significantly lowerrately measured by microneurographic techniques. Us-
ing these techniques, Converse and colleagues reported values for baroreceptor sensitivity than expected [81].
These findings were confirmed later in a non-invasiveincreased sympathetic nerve discharge in 23 hemodialy-
sis-dependent patients compared to 11 control subjects, study of 12 patients (6 hypotension-prone) by Pelosi and
colleagues. In addition, these authors reported a pro-reflecting sympathetic hyperactivity [71]. Interestingly,
they also reported evidence of higher sympathetic dis- gressive reduction in the low frequency power of systolic
blood pressure variability, which dramatically reducedcharge in those 18 hemodialysis-dependent patients with
native kidneys compared to 5 patients with bilateral ne- at the time of vascular collapse, indicating sympathetic
nervous system dysfunction (Table 5) [60]. Similar ab-phrectomies, and suggested that chronic renal failure is
associated with reversible sympathetic activation medi- normalities with respect to sympathetic autonomic dys-
function also have been reported for pulse interval vari-ated by the failing kidney [71]. More recently, Ligtenberg
and colleagues have reported increased muscle sympa- ability (Table 5) [47, 58, 59]. However, some researchers
have found both combined parasympathetic and sympa-thetic activity using these techniques in dialysis-indepen-
dent chronic renal failure patients, which is implicated thetic dysfunction from reduced low and high frequency
pulse interval spectral power [47] or isolated parasympa-in the associated hypertension and controlled by angio-
tensin-converting enzyme inhibitor therapy [72]. thetic dysfunction from reduced heart rate variability [65].
Not all studies have reported evidence of autonomic
dysfunction in patients with intradialytic hypotension
OTHER EFFECTS OF DIALYSIS ON
[6, 25, 30, 83]. However, this may reflect methodological
CARDIOVASCULAR AUTONOMIC FUNCTION
issues related to hemodynamic measures and subject se-
Intra-dialytic hypotension lection. Straver and colleagues assessed autonomic func-
tion from heart rate variability to respiration, orthostasisAcute hypotension is an important complication of
hemodialysis treatment, occurring in up to one-third of and Valsalva maneuver in 10 hypotensive compared to
18 nonhypotensive hemodialysis patients and identifieddialysis sessions [73, 74]. Two clinical types of intra-dialytic
hypotension have been recognized: a relatively asymp- no differences in baseline autonomic function, though
changes in autonomic parameters during dialysis were nottomatic gradual blood pressure reduction accompanied
by a heart rate increase, and a more abrupt blood pres- studied [83]. Vita and colleagues identified 8 of a group
of 22 hemodialysis patients with intradialytic hypotension,sure fall accompanied by a bradycardia and symptoms
of cramps, nausea and vomiting [75, 76]. While reduced though 6 patients had normal autonomic function tests
[30]. Similarly, studies estimating plasma norepinephrinecardiac performance secondary to left ventricular hyper-
trophy and myocardial interstitial fibrosis has been impli- as a measure of sympathetic activity have reported in-
creased levels compared to control subjects in both hypo-cated in this condition [77, 78], the failure of cardiovascu-
lar autonomic regulatory mechanisms also is likely to be tension-prone and non-hypotension–prone hemodialy-
sis patients [24, 65]. However, Takahashi and colleaguesof importance.
In keeping with this premise, a number of groups have found the highest plasma noradrenaline levels in 10 hy-
potensive compared to 11 non-hypotensive hemodialysisreported impairment in cardiac baroreceptor sensitivity
in hemodialysis patients with intradialytic hypotension patients and 10 control subjects, probably reflecting poor
end-organ catecholamine responsiveness [47].[7, 8, 20, 79–82]. Kersh and colleagues studied 8 patients
with intradialytic hypotension, and identified two differ-
Peritoneal dialysisent patient groups. Two patients demonstrated a normal
heart rate and blood pressure response to the Valsalva Low [84] and middle molecular weight [85] substances
have been incriminated as factors in uremic neuropathy.maneuver, and the hypotension responded to a fluid chal-
lenge. However, the other six patients had evidence of Peritoneal dialysis leads to more effective clearance of
these substances when compared to hemodialysis and,autonomic dysfunction, did not respond to a fluid chal-
lenge, but responded to norepinephrine [79]. Again, Lil- therefore, it has been suggested that peritoneal dialysis
may be more effective than hemodialysis in reversingley, Golden and Stone found evidence of impaired baro-
receptor sensitivity in 10 patients with dialysis-induced uremia-related autonomic nervous system dysfunction.
This has only been formally assessed in a few studieshypotension, though baroreceptor sensitivity was normal
in 10 patients without this complication. However, both [27, 28, 45]. One small study compared 12 hemodialysis
and 10 peritoneal dialysis to 12 control subjects. Reducedgroups demonstrated normal blood pressure responses
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Table 5. Results of studies assessing autonomic nervous system function by spectral analysis techniques in stable (normotensive) and
unstable (hypotension-prone) hemodialysis-dependent chronic renal failure patients
Study Population Test Findings
Takahashi et al, 11 Stable PI spectra (AR) – Reduced LF (0.04–0.14 Hz) power in Unstable vs. Stable supine (4 vs 11 msec2)
1996 [47] 10 Unstable and standing (5 vs. 12 msec2)
– Reduced HF (0.25 Hz) power in Unstable vs. Stable supine (7 vs. 15 msec2) and
standing (6 vs. 11 msec2)
– Reduced LF/HF ratio in Unstable vs. Stable supine (0.4 vs. 0.7) and standing
(0.6 vs. 1.1)
Calvacanti et al, 15 Stable PI spectra (AR) – Stable patients exhibited predominantly LF (0.06–0.15 Hz) power during HD
1997 [58] 15 Unstable – Unstable patients exhibited predominantly HF (0.15–0.4 Hz) power during HD
– LF/HF ratio was greater in Stable than Unstable patients throughout HD
Barnas et al, 11 Stable PI spectra (FFT) – No significant differences were seen in baseline LF (0.04–0.15 Hz)/HF
1999 [59] 8 Unstable (0.15–0.4 Hz) ratio between Unstable vs. Stable groups (1.12 vs. 1.65)
– In Stable HD sessions, LF power increased (45.2 to 59.9 nu) and HF power
reduced (54.8 to 40.2 nu)
– In Unstable sessions, hypotension was associated with a sudden fall in LF power
(62.8 to 40.0 nu) and rise in HF power (37.9 to 60.3 nu)
Pelosi et al, 1999 6 Stable PI spectra (AR) – PI spectra: LF (0.03–0.15 Hz)/HF (0.15–0.4 Hz) ratio changes were significantly
[60] 6 Unstable SBP spectra (AR) different at time of maximal BP decrease between Unstable and Stable patients
(2.9 vs. 3.7), predominantly reflecting increased LF power in Stable group
– SBP spectra: LF power changes were significantly different at time of maximal
BP decrease between Unstable and Stable patients (8.6 vs. 13.3 mm Hg2)
Abbreviations are: HD, hemodialysis; SBP, systolic blood pressure; FFT, fast Fourier Transform; LF, low frequency; PI, pulse interval; AR, autoregressive; HF,
high frequency; nu, normalized units.
heart rate variability to respiration, orthostatic change [89, 90]. These differences may relate to comorbid factors
predisposing to autonomic neuropathy and the use ofand the Valsalva maneuver was observed in both dialysis
immunosuppressive medication, which may affect auto-groups, reflecting impaired parasympathetic nervous sys-
nomic function.tem activity. No significant differences were observed in
Nonetheless, a number of studies have reported sig-blood pressure response to the orthostatic change be-
nificant improvement in cardiovascular autonomic func-tween control and both dialysis groups, indicating an
tion. The reported improvements have been in parasym-intact sympathetic nervous system function [28]. Simi-
pathetic nervous system function by the assessment oflarly, Malik, Winney and Ewing did not identify any dif-
heart rate responses to respiration, orthostatic changeferences in autonomic score (reflecting the number of
and Valsalva maneuver [19, 21, 28, 93]. Improvementsabnormal or borderline tests of parasympathetic and
have been seen in sympathetic nervous system func-sympathetic function) between 40 hemodialysis and 8
tion by assessing blood pressure responses to orthostaticperitoneal dialysis patients [27]. Similar results have been
change and sustained handgrip [19, 21]. Rockel and col-observed using power spectral analysis techniques. Axel-
leagues studied 16 patients at 3 and 18 months post-renalrod and colleagues reported reduced low, middle and
transplantation, and reported an improvement in chronichigh frequency powers of pulse interval variability in all
renal failure-induced autonomic dysfunction with similardialysis patients compared to controls, though there were
heart rate and blood pressure responses to the Valsalvano significant differences between hemodialysis and peri-
maneuver and orthostatic change to those found in con-toneal dialysis patients [45].
trol subjects [19]. Reversal in baroreceptor sensitivity
also was demonstrated following renal transplantation
EFFECTS OF RENAL TRANSPLANTATION ON by newer time-domain [17] as well as frequency-domain
CARDIOVASCULAR AUTONOMIC FUNCTION techniques [48].
Cardiovascular morbidity and mortality remains a sig- One main disadvantage to all these studies is that they
nificant problem within the renal transplant population, compare dialysis-dependent chronic renal failure patient
accounting for 15% of all deaths [86–88]. Therefore, it groups with different groups of post-renal transplant pa-
would be very interesting to establish the effects of renal tients. However, longitudinal studies of chronic renal
transplantation on cardiovascular autonomic function. failure patients appear to confirm the observation that
A number of studies have demonstrated no [31, 89–91] cardiovascular autonomic dysfunction is reversed by re-
or only minimal [92] improvement in autonomic neurop- nal transplantation. Agarwal and colleagues reported a
athy following combined renal and islet cell transplanta- small subgroup of 12 patients who underwent renal trans-
tion for diabetic nephropathy. However, substantial im- plantation. The baroreceptor sensitivity slope to bolus
phenylephrine had improved when patients were furtherprovement in peripheral neuropathy has been reported
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studied a mean of 24 weeks following transplantation. [96]. In a study of 144 hemodialysis patients, Tozawa
Improvements were also seen in parasympathetic, but not and colleagues reported that the hazard ratio for death
sympathetic, cardiovascular autonomic function assessed from all causes increased 1.63 times per 1% increase in
by heart rate responses to respiration, orthostatic change the coefficient of variation in systolic blood pressure
and Valsalva maneuver and blood pressure changes to (95% CI 1.05 to 2.53). The hazard ratio for death from
cold pressor, mental arithmetic and sudden loud noise cardiovascular causes increased by 1.78 times per 1%
stimuli, respectively [8]. In another study, Yildiz and col- increase (95% CI 0.94 to 3.37) [97].
leagues studied 14 hemodialysis patients before and a The use of power spectral analysis techniques also
mean of 4.6 months following renal transplantation. is yielding important prognostic information. Takahashi
They reported an increase in low and high frequency and colleagues have reported a significantly lower high
spectral power of pulse interval variability, though no frequency pulse interval power in 8 hemodialysis patients
change in the low-to-high frequency ratio as a marker dying of sudden cardiac death, indicating reduced para-
of sympathovagal balance [94]. sympathetic nervous system activity. These changes were
in comparison with a group of 23 patients surviving for
at least three years following cardiac catheterization (ab-PROGNOSTIC SIGNIFICANCE OF IMPAIRED
stract; Takahashi et al, J Am Soc Nephrol 6:564, 1995).CARDIOVASCULAR AUTONOMIC FUNCTION
Importantly, cardiovascular autonomic dysfunction may
be of prognostic significance. As previously discussed, CONCLUSIONS
baroreceptor sensitivity is important in the short-term In summary, chronic renal failure patients demon-
regulation of the cardiovascular system. Certainly, im- strate evidence of autonomic dysfunction using both clas-
paired cardiac baroreceptor sensitivity is associated with sical and newer non-invasive techniques of assessment.
an increased risk of cardiovascular death following myo- There is significant consensus regarding abnormalities of
cardial infarction, even allowing for other important prog- the parasympathetic nervous system, though conclusions
nostic factors, such as left ventricular dysfunction [95]. are less clear-cut with respect to sympathetic nervous
Interestingly, Jassal and colleagues have reported higher system function. Furthermore, there is evidence of im-
incidences of cardiac arrhythmias in hemodialysis patients paired cardiac baroreceptor sensitivity, which is impor-
with associated autonomic dysfunction on standard tests. tant in the overall integrity of cardiovascular autonomic
These arrhythmias include: ventricular ectopics (24%), control. These findings may be of clinical importance, and
paroxysmal atrial fibrillation (11%), and ventricular tachy- may be related to increased cardiovascular morbidity
cardia (8%) [33]. Furthermore, Hathaway and colleagues and mortality as well as intra-dialytic hypotension. The
have reported abnormalities of 24-hour heart rate vari- underlying mechanisms require further study before
ability using power spectral analysis techniques in 278 treatment strategies can be developed.
dialysis-dependent and dialysis-independent diabetic and
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